These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22240444)

  • 1. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic and secondary membranous nephropathies].
    Ronco P; Debiec H
    Presse Med; 2012 Mar; 41(3 Pt 1):290-7. PubMed ID: 22208961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of membranous nephropathy: recent advances and future challenges.
    Ronco P; Debiec H
    Nat Rev Nephrol; 2012 Feb; 8(4):203-13. PubMed ID: 22371247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of idiopathic membranous nephropathy.
    Waldman M; Austin HA
    J Am Soc Nephrol; 2012 Oct; 23(10):1617-30. PubMed ID: 22859855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.
    Ronco P; Debiec H
    Mol Immunol; 2015 Nov; 68(1):57-62. PubMed ID: 26597209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of membranous nephropathy: update.
    Kwatra IS; Prasher PK
    J Assoc Physicians India; 2013 Nov; 61(11):807-10. PubMed ID: 24974493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranous nephropathy.
    Mathieson PW
    Clin Med (Lond); 2012 Oct; 12(5):461-6. PubMed ID: 23101149
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular Pathogenesis of Membranous Nephropathy.
    Ronco P; Debiec H
    Annu Rev Pathol; 2020 Jan; 15():287-313. PubMed ID: 31622560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.
    Beck LH; Fervenza FC; Beck DM; Bonegio RG; Malik FA; Erickson SB; Cosio FG; Cattran DC; Salant DJ
    J Am Soc Nephrol; 2011 Aug; 22(8):1543-50. PubMed ID: 21784898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous glomerulopathy: the evolving story.
    Ronco P; Debiec H
    Curr Opin Nephrol Hypertens; 2010 May; 19(3):254-9. PubMed ID: 20110811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
    Ronco P; Debiec H
    Lancet; 2015 May; 385(9981):1983-92. PubMed ID: 26090644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of membranous nephropathy: evolution and revolution.
    Glassock RJ
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membranous nephropathy: up to date].
    Imai E
    Nihon Jinzo Gakkai Shi; 2011; 53(5):692-6. PubMed ID: 21842602
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous Nephropathy: Updates on Management.
    Bharati J; Waguespack DR; Beck LH
    Adv Kidney Dis Health; 2024 Jul; 31(4):299-308. PubMed ID: 39084755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous nephropathy: recent travels and new roads ahead.
    Beck LH; Salant DJ
    Kidney Int; 2010 May; 77(9):765-70. PubMed ID: 20182413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies.
    Brenchley PE
    J Am Soc Nephrol; 2015 Oct; 26(10):2308-11. PubMed ID: 25804283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.